litlas
ログインアカウント作成

Marcela V. Maus

1999–2026 年に発表

162
論文数
32,151
被引用数
84
h 指数
151
i10 指数

被引用数

Marcela V. Maus の年別被引用数1990 年: 被引用 2 件1991 年: 被引用 1 件1997 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 10 件2003 年: 被引用 20 件2004 年: 被引用 22 件2005 年: 被引用 10 件2006 年: 被引用 9 件2007 年: 被引用 22 件2008 年: 被引用 41 件2009 年: 被引用 36 件2010 年: 被引用 29 件2011 年: 被引用 23 件2012 年: 被引用 17 件2013 年: 被引用 51 件2014 年: 被引用 84 件2015 年: 被引用 164 件2016 年: 被引用 213 件2017 年: 被引用 257 件2018 年: 被引用 347 件2019 年: 被引用 1,129 件2020 年: 被引用 1,860 件2021 年: 被引用 2,139 件2022 年: 被引用 2,122 件2023 年: 被引用 1,868 件2024 年: 被引用 3,029 件2025 年: 被引用 1,895 件2026 年: 被引用 65 件1992〜1996 年は被引用が無いため表示していません1998〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,111 件、この内訳の 32.5%中国: 引用元論文 2,404 件、この内訳の 15.3%ドイツ: 引用元論文 1,052 件、この内訳の 6.7%イギリス: 引用元論文 745 件、この内訳の 4.7%イタリア: 引用元論文 571 件、この内訳の 3.6%フランス: 引用元論文 537 件、この内訳の 3.4%スペイン: 引用元論文 466 件、この内訳の 3%カナダ: 引用元論文 407 件、この内訳の 2.6%スイス: 引用元論文 404 件、この内訳の 2.6%オランダ: 引用元論文 346 件、この内訳の 2.2%オーストラリア: 引用元論文 340 件、この内訳の 2.2%日本: 引用元論文 260 件、この内訳の 1.7%
0%32.5%その他 19.5%

機関

分野

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology15.7%
  • Immunology and Microbiology9%
  • Engineering2.1%
  • Materials Science0.8%
  • Neuroscience0.4%
  • その他0.7%

トピック

  • CAR-T cell therapy research21.5%
  • Virus-based gene therapy research6.3%
  • Immunotherapy and Immune Responses6%
  • Immune Cell Function and Interaction5.8%
  • Nanowire Synthesis and Applications3.9%
  • Cancer Immunotherapy and Biomarkers3.6%
  • その他52.9%

共著者

全論文

検索で開く
  1. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    著者: Daniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle, Jennifer N. Brudno, Marcela V. Maus, Jae H. Park, Elena Mead, Steven Z. Pavletic, William Y. Go, Lamis Eldjerou, Rebecca Gardner, Noelle V. Frey, Kevin J. Curran, Karl S. Peggs, Marcelo C. Pasquini, John F. DiPersio, Marcel R.M. van den Brink, Krishna V. Komanduri, Stephan A. Grupp, Sattva S. Neelapu - Biology of Blood and Marrow Transplantation 2018 被引用: 3,445

  2. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    著者: Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai, J. Joseph Melenhorst, Keith G. Mansfield, Jennifer J.D. Morrissette, Maria Martinez‐Lage, Steven Brem, Eileen Maloney, Angela Shen, Randi Isaacs, Suyash Mohan, Gabriela Plesa, Simon F. Lacey, Jean‐Marc Navenot, Zhaohui Zheng, Bruce L. Levine, Hideho Okada, Carl H. June, Jennifer L. Brogdon, Marcela V. Maus - Science Translational Medicine 2017 被引用: 1,772

  3. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

    著者: Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer - New England Journal of Medicine 2019 被引用: 1,738

  4. Recent advances and discoveries in the mechanisms and functions of CAR T cells

    著者: Rebecca C. Larson, Marcela V. Maus - Nature reviews. Cancer 2021 被引用: 850

  5. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

    著者: Bryan D. Choi, Elizabeth R. Gerstner, Matthew J. Frigault, Mark B. Leick, Christopher Mount, Leonora Balaj, Sarah Nikiforow, Bob S. Carter, William T. Curry, Kathleen Gallagher, Marcela V. Maus - New England Journal of Medicine 2024 被引用: 402

  6. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

    著者: Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei‐Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, S. Church, Tyler Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney L. Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Diane Frazee, Mary Truran, Elizabeth Veloso, Holly McConville, Jonathan Aguedelo, Samantha Hower, Sophia Ngo, Julie K. Jadlowsky, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Minnal Gupta, Farzana Nazimuddin, Chelsie Bartoszek, Natalka Koterba, Rachael Reynolds, Farris Ellington, Christopher C. Kloss, Ji‐Hyun Lee, Yangbing Zhao, John Scholler, James L. Riley, Christina Bailey, Andrew J. P. White, Briana M. Hudson, Pearl Chang, Marcela V. Maus, Bruce L. Levine, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta, Naomi B. Haas - Nature Medicine 2022 被引用: 500

  7. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

    著者: Melissa Hines, Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed, Matthew J. Frigault, Joshua A. Hill, Michael D. Jain, William T. Johnson, Yi Lin, Kris M. Mahadeo, Gabriela Marón, Rebecca Marsh, Sattva S. Neelapu, Sarah Nikiforow, Amanda K. Ombrello, Nirav N. Shah, Aimee C. Talleur, David P Turicek, Anant Vatsayan, Sandy W. Wong, Marcela V. Maus, Krishna V. Komanduri, Nancy Berliner, Jan‐Inge Henter, Miguel‐Angel Perales, Noelle V. Frey, David T. Teachey, Matthew J. Frank, Nirali N. Shah - Transplantation and Cellular Therapy 2023 被引用: 304

  8. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

    著者: Bryan D. Choi, Xiaoling Yu, Ana P. Castaño, Amanda A. Bouffard, Andrea Schmidts, Rebecca C. Larson, Stefanie R. Bailey, Angela C. Boroughs, Matthew J. Frigault, Mark B. Leick, Irene Scarfò, Curtis L. Cetrulo, Shadmehr Demehri, Brian V. Nahed, Daniel P. Cahill, Hiroaki Wakimoto, William T. Curry, Bob S. Carter, Marcela V. Maus - Nature Biotechnology 2019 被引用: 558

  9. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing

    著者: Benjamin P. Kleinstiver, Alexander A. Sousa, Russell T. Walton, Y. Esther Tak, Jonathan Y. Hsu, Kendell Clement, Moira M. Welch, Joy E. Horng, Jose Malagon-Lopez, Irene Scarfò, Marcela V. Maus, Luca Pinello, Martin J. Aryee, J. Keith Joung - Nature Biotechnology 2019 被引用: 724

  10. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

    著者: Bruce L. Levine, Marcelo C. Pasquini, John E. Connolly, David L. Porter, Michael P. Gustafson, Jaap Jan Boelens, Edwin M. Horwitz, Stephan A. Grupp, Marcela V. Maus, Frederick L. Locke, Fabio Ciceri, Annalisa Ruggeri, John A. Snowden, Helen E. Heslop, Crystal L. Mackall, Carl H. June, Anna M. Sureda, Miguel‐Angel Perales - Nature Medicine 2024 被引用: 196

  11. Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication

    著者: Christopher C. Kloss, Ji‐Hyun Lee, Aaron Zhang, Fang Chen, J. Joseph Melenhorst, Simon F. Lacey, Marcela V. Maus, Joseph A. Fraietta, Yangbing Zhao, Carl H. June - Molecular Therapy 2018 被引用: 623

  12. CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours

    著者: Rebecca C. Larson, Michael C. Kann, Stefanie R. Bailey, Nicholas J. Haradhvala, Paula Montero Llopis, Amanda A. Bouffard, Irene Scarfò, Mark B. Leick, Korneel Grauwet, Trisha R. Berger, Kai Stewart, Praju Vikas Anekal, Max Jan, Julia Joung, Andrea Schmidts, Tamara Ouspenskaia, Travis Law, Aviv Regev, Gad Getz, Marcela V. Maus - Nature 2022 被引用: 349

  13. Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

    著者: Li Tang, Yiran Zheng, Mariane B. Melo, Llian Mabardi, Ana P. Castaño, Yuqing Xie, Na Li, Sagar B. Kudchodkar, Hing C. Wong, Emily K. Jeng, Marcela V. Maus, Darrell J. Irvine - Nature Biotechnology 2018 被引用: 646

  14. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

    著者: Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, Oana Mirci‐Danicar, Giovanna Lucchini, Danielle Pinner, Nitin Jain, Hagop M. Kantarjian, Nicolas Boissel, Marcela V. Maus, Matthew J. Frigault, André Baruchel, Mohamad Mohty, Athos Gianella-Borradori, Florence Binlich, Svetlana Balandraud, Fabien Vitry, E. W. Prosser Thomas, Anne Philippe, Sylvain Fouliard, Sandra Dupouy, Ibtissam Marchiq, Maria Almena-Carrasco, Nicolas Ferry, Sylvain Arnould, Cyril Konto, Paul Veys, Waseem Qasim, Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jóźwik, Antonio Pagliuca, Ghulam Mufti, Piers Patten, Shireen Kassam, Stephen Devereux, Majid Kazmi, Kirsty Cuthill, Victoria Potter, Andrea Kühnl, Victoria Metaxa, Laarni Bonganay, Orla Stewart, Rose Ellard, Lorraine Catt, Jen Lewis, Farzin Farzaneh, Jackie Chappell, Alice Mason, Vicky Chu, Alan Dunlop, Adeel Saleem, Gary Cheung, Helena Munro, Elka Giemza, Waseem Qasim, Paul Veys, Oana Ciocârlie, Giovanna Lucchini, Danielle Pinner, Jan Chu, Persis Amrolia, Kanchan Rao, Robert Chiesa, Juliana Silva, Annette Hill, Maria Finch, Lindsey Young, Harvinder Hara, Sujith Samarasinghe, Anupama Rao, Ajay Vora, Anupama Rao, Christine Rivat, Clare Murphy, Gulrukh Ahsan, Rasha Said Shamsah, Jesmina James, Sarah Inglott, Gary Wright, Stuart Adams, Natalia Izotova, Nitin Jain, Marina Konopleva, William G. Wierda, Elias Jabbour, Hagop M. Kantarjian, Partow Kebrieai, Emily Jones, Kara McGee, Marcela V. Maus, Matthew J. Frigault, Jami Brown, Vesselina Toncheva, Keagan S. Casey, Hanno Hock, Meaghan A McKeown, Richard Mathews ほか 40 名 - The Lancet 2020 被引用: 360

  15. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

    著者: Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus, Aaron P. Rapoport, Bruce L. Levine, Lyndsey Emery, Leslie A. Litzky, Adam Bagg, Beatriz M. Carreno, Patrick J. Cimino, Gwendolyn Binder-Scholl, Dominic Smethurst, Andrew B. Gerry, Nick Pumphrey, Alan Bennett, Joanna E. Brewer, Joseph Dukes, Jane Harper, Helen K. Tayton-Martin, Bent K. Jakobsen, Namir J. Hassan, Michael Kalos, Carl H. June - Blood 2013 被引用: 1,163

  16. The Emerging Landscape of Immune Cell Therapies

    著者: Evan W. Weber, Marcela V. Maus, Crystal L. Mackall - Cell 2020 被引用: 459

  17. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

    著者: Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven Μ. Albelda, Michael Kalos, Carl H. June - Cancer Immunology Research 2013 被引用: 860

  18. Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System

    著者: Magdi Elsallab, Moataz Ellithi, Matthew A. Lunning, Christopher R. D’Angelo, Jihyun Ma, Miguel‐Angel Perales, Matthew J. Frigault, Marcela V. Maus - Blood 2024 被引用: 137

  19. Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies

    著者: Marco Ruella, Felix Korell, Patrizia Porazzi, Marcela V. Maus - Nature Reviews Drug Discovery 2023 被引用: 155

  20. Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

    著者: Max Jan, Irene Scarfò, Rebecca C. Larson, Amanda Walker, Andrea Schmidts, Andrew A. Guirguis, Jessica A. Gasser, Mikołaj Słabicki, Amanda A. Bouffard, Ana P. Castaño, Michael C. Kann, Maria L. Cabral, Alexander Tepper, Daniel E. Grinshpun, Adam S. Sperling, Taeyoon Kyung, Quinlan Sievers, Michael E. Birnbaum, Marcela V. Maus, Benjamin L. Ebert - Science Translational Medicine 2021 被引用: 258

  21. The future of engineered immune cell therapies

    著者: Darrell J. Irvine, Marcela V. Maus, David Mooney, Wilson W. Wong - Science 2022 被引用: 190

  22. Engineering and Design of Chimeric Antigen Receptors

    著者: Sònia Guedan, Hugo Calderón, Avery D. Posey, Marcela V. Maus - Molecular Therapy — Methods & Clinical Development 2018 被引用: 447

  23. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

    著者: Bryan D. Choi, Xiaoling Yu, Ana P. Castaño, Henia Darr, Daniel B. Henderson, Amanda A. Bouffard, Rebecca C. Larson, Irene Scarfò, Stefanie R. Bailey, Genevieve M. Gerhard, Matthew J. Frigault, Mark B. Leick, Andrea Schmidts, Jason Sagert, William T. Curry, Bob S. Carter, Marcela V. Maus - Journal for ImmunoTherapy of Cancer 2019 被引用: 283

  24. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

    著者: Marcela V. Maus, S. Alexander, Michael R. Bishop, Jennifer N. Brudno, Colleen Callahan, Marco L. Davila, Claudia Diamonte, Jörg Dietrich, Julie C. Fitzgerald, Matthew J. Frigault, Terry J. Fry, Jennifer Holter‐Chakrabarty, Krishna V. Komanduri, Daniel W Lee, Frederick L. Locke, Shannon L. Maude, Philip L. McCarthy, Elena Mead, Sattva S. Neelapu, Tomas G. Neilan, Bianca Santomasso, Elizabeth J. Shpall, David T. Teachey, Cameron J. Turtle, Tom Whitehead, Stephan A. Grupp - Journal for ImmunoTherapy of Cancer 2020 被引用: 269